Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors

Wei Liu, Hu Zhou, Ruibin Huang, Xin Du, ZePing Zhou, Changcheng Zheng, Shifeng Lou, Xinyue Dai, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2024-199149

Published: 2024

Journal Articles

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Feng Xue, Mankai Ju, Tienan Zhu, ZePing Zhou, Jing Sun, Linhua Yang, Zhenyu Yan, Hu Zhou, Xin Du, Changcheng Zheng, Xia Wu, Xiao Xiao, Renchi Yang, Lei Zhang

Blood (2024) 144 (Supplement 1): 3582.

https://doi.org/10.1182/blood-2024-204715

Published: 2024

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

The Efficacy of Risk Score System Establishment and Methylprednisolone Stratification Treatment for Pre-Engraftment Syndrome after Unrelated Cord Blood Transplantation: A Retrospective (development) and a Prospective (validation) Study

Xiaoyu Zhu, Jiang Zhu, Baolin Tang, Kaidi Song, Linlin Jin, Huilan Liu, Changcheng Zheng, Liangquan Geng, Xuhan Zhang, Wen Yao, Xiang Wan, Juan Tong, Guangyu Sun, Zimin Sun

Blood (2019) 134 (Supplement_1): 4501.

https://doi.org/10.1182/blood-2019-123952

Published: 2019

Journal Articles

Prospective Cohort Study Comparing Intravenous Busulfan Versus Total Body Irradiation in Cord Blood Transplantation

Blood (2018) 132 (Supplement 1): 5709.

https://doi.org/10.1182/blood-2018-99-118681

Published: 2018

Journal Articles

The Embt Risk Score Predicts the Outcome of Patients with Leukaemia Receiving Single Umbilical Cord Blood Transplantation

Xiaoyu Zhu, Baolin Tang, Changcheng Zheng, PhD, Huilan Liu, Liangquan Geng, Juan Tong, MD, Lei Zhang, Xuhan Zhang, Wen Yao, Kaidi Song, Xingbing Wang, MD, Kaiyang Ding, PhD, Zimin Sun, MD

Blood (2016) 128 (22): 2275.

https://doi.org/10.1182/blood.V128.22.2275.2275

Published: 2016

Journal Articles

Intensified Myeloablative Conditioning Regimen without Antithymocytic (ATG) Results in Superior Patient Outcome Compared to Myeloablative Conditioning Regimen for Single-Unit Umbilical Cord Blood Transplantation in Hematological Malignancies

Zimin Sun, MD, Huilan Liu, Yue Wu, Changcheng Zheng, PhD, Baolin Tang, Xiaoyu Zhu, Qifa Liu

Blood (2016) 128 (22): 5837.

https://doi.org/10.1182/blood.V128.22.5837.5837

Published: 2016

Journal Articles

Rapid B-Cell Recovery Is Predictive of Graft-Versus-Host Disease-Free Survival, Few Infectious Events, and Good Quality-of-Life after Cord Blood Transplantation Using Myeloablative Regimen without Antithymocyte Globulin

Liu Huilan, MD, Sun Zimin, MD, Zhu Xiaoyu, MD, Baolin Tang, Changcheng Zheng, PhD, TONG Juan, MD, Song Kaidi, MD, Zhang Lei, MD, Xiu Han, MD, Yao Wen, Sun Guangyu, MD, Wu Yue, MD, Wang Xingbing, MD, Ding Kaiyang, Ding Bangsheng, MD, Zhang Aimei, Geng Liangquan, MD, Wan Xiang, MD PhD

Blood (2016) 128 (22): 4675.

https://doi.org/10.1182/blood.V128.22.4675.4675

Published: 2016

Journal Articles

UCBT Using Myeloablative Conditioning Regimen without ATG Has Similar Survival but Better Life Quality Compared with Upbsct for Adults with Primary Acute Leukemia-a Multicenter Study in China

Juan Tong, MD, Li Xuan, Yanling Sun, Changcheng Zheng, PhD, Huilan Liu, Xiaoyu Zhu, Baolin Tang, Qifa Liu, MD, Dongjun Lin, Zimin Sun, MD

Blood (2016) 128 (22): 5859.

https://doi.org/10.1182/blood.V128.22.5859.5859

Published: 2016

Journal Articles

Impact of ABO Incompatibility on Engraftment , Transfusion Requirement and Survival after Unrelated Cord Blood Transplantation：a Single Institute Experience in China

Jiawei Yan, Guangyu Sun, Wen Yao, MD, Lei Zhang, Xiang Wan, Baolin Tang, Xiaoyu Zhu, Kaiyang Ding, PhDMD, Changcheng Zheng, MD, Huilan Liu, Zimin Sun

Blood (2014) 124 (21): 2586.

https://doi.org/10.1182/blood.V124.21.2586.2586

Published: 2014

Journal Articles

Intensified Myeloablative Unrelated Cord Blood Transplantation for High-Risk or Advanced Hematological Malignancies: Experience at a Single-Institution in China

Zimin Sun, Huilan Liu, Baolin Tang, Xiaoyu Zhu, Wen Yao, Juan Tong, MD, Kaidi Song, Liangquan Geng, Xingbing Wang, PhD MD, Kaiyang Ding, PhD, Changcheng Zheng, MD, Weibo Zhu

Blood (2014) 124 (21): 1222.

https://doi.org/10.1182/blood.V124.21.1222.1222

Published: 2014

Journal Articles

CMV Infection Alone Does Not Affect The Survival In Patients After Umbilical Cord Blood Transplantation: Can We Put Off The Time Of Preemptive Therapy?

Juan Tong, III, Zimin Sun, MD, Huilan Liu, MD, Kaiyang Ding, PhD, MD, Liangquan Geng, MD, Changcheng Zheng, MD, Baolin Tang, Xin Liu, MD

Blood (2013) 122 (21): 5458.

https://doi.org/10.1182/blood.V122.21.5458.5458

Published: 2013

Journal Articles

Pre-Engraftment Syndrome After Myeloablative Umbilical Cord Blood Transplantation: Risk Factors and How To Stratify

Zimin Sun, MD, Maojing Guan, MD, Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Changcheng Zheng, MD, Juan Tong, MD, Baolin Tang, MD, Wen Yao, MD

Blood (2013) 122 (21): 5482.

https://doi.org/10.1182/blood.V122.21.5482.5482

Published: 2013

Journal Articles

Outcomes of Unrelated Umbilical Cord Blood Transplantation Using a Conditioning Regimen of TBI/Ara-c/CY without ATG for Adolescent and Adults Patients with High-Risk Hematologic Malignancies

Zimin Sun, MD, Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Juan Tong, MD, Baolin Tang, MD, Chenyang Zhou, MD, Wen Yao, MD, Yun Wu, Changcheng Zheng, MD, Xin Liu, MD, Weibo Zhu, MD, Zhuyi Wang, MD

Blood (2012) 120 (21): 4525.

https://doi.org/10.1182/blood.V120.21.4525.4525

Published: 2012

Journal Articles

Similar Survival, but Better Quality of Life After Myeloablative Transplantation Using Unrelated Cord Blood Versus Identical Sibling Hematopoietic Cells in Adults with Hematologic Malignancies: A Single Institute Analysis.

Huilan Liu, MD, Liangquan Geng, MD, Xingbing Wang, PhD, MD, Kaiyang Ding, PhD, MD, Juan Tong, MD, Baolin Tang, MD, Chenyang Zhou, MD, Yun Wu, Wen Yao, MD, Changcheng Zheng, MD, Xin Liu, MD, Weibo Zhu, MD, Zhuyi Wang, MD, Zimin Sun, MD

Blood (2012) 120 (21): 3134.

https://doi.org/10.1182/blood.V120.21.3134.3134

Published: 2012

NARROW

A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors

Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

The Efficacy of Risk Score System Establishment and Methylprednisolone Stratification Treatment for Pre-Engraftment Syndrome after Unrelated Cord Blood Transplantation: A Retrospective (development) and a Prospective (validation) Study

Prospective Cohort Study Comparing Intravenous Busulfan Versus Total Body Irradiation in Cord Blood Transplantation

The Embt Risk Score Predicts the Outcome of Patients with Leukaemia Receiving Single Umbilical Cord Blood Transplantation

Intensified Myeloablative Conditioning Regimen without Antithymocytic (ATG) Results in Superior Patient Outcome Compared to Myeloablative Conditioning Regimen for Single-Unit Umbilical Cord Blood Transplantation in Hematological Malignancies

Rapid B-Cell Recovery Is Predictive of Graft-Versus-Host Disease-Free Survival, Few Infectious Events, and Good Quality-of-Life after Cord Blood Transplantation Using Myeloablative Regimen without Antithymocyte Globulin

UCBT Using Myeloablative Conditioning Regimen without ATG Has Similar Survival but Better Life Quality Compared with Upbsct for Adults with Primary Acute Leukemia-a Multicenter Study in China

Impact of ABO Incompatibility on Engraftment , Transfusion Requirement and Survival after Unrelated Cord Blood Transplantation：a Single Institute Experience in China

Intensified Myeloablative Unrelated Cord Blood Transplantation for High-Risk or Advanced Hematological Malignancies: Experience at a Single-Institution in China

CMV Infection Alone Does Not Affect The Survival In Patients After Umbilical Cord Blood Transplantation: Can We Put Off The Time Of Preemptive Therapy?

Pre-Engraftment Syndrome After Myeloablative Umbilical Cord Blood Transplantation: Risk Factors and How To Stratify

Outcomes of Unrelated Umbilical Cord Blood Transplantation Using a Conditioning Regimen of TBI/Ara-c/CY without ATG for Adolescent and Adults Patients with High-Risk Hematologic Malignancies

Similar Survival, but Better Quality of Life After Myeloablative Transplantation Using Unrelated Cord Blood Versus Identical Sibling Hematopoietic Cells in Adults with Hematologic Malignancies: A Single Institute Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only